Jiangsu Lanfeng Bio-chemical Co Ltd Market Cap ($234.13 Million)
Market Cap & Net Worth: Jiangsu Lanfeng Bio-chemical Co Ltd (002513)
Jiangsu Lanfeng Bio-chemical Co Ltd market cap. Jiangsu Lanfeng Bio-chemical Co Ltd (SHE:002513) has a market capitalization of $234.13 Million (CN¥1.60 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #15749 globally and #4559 in its home market, demonstrating a -7.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Lanfeng Bio-chemical Co Ltd's stock price CN¥4.26 by its total outstanding shares 375593978 (375.59 Million). Also see cash flow conversion of Jiangsu Lanfeng Bio-chemical Co Ltd for how efficiently the company converts equity into cash flow.
Jiangsu Lanfeng Bio-chemical Co Ltd Market Cap History (2015–2026)
Jiangsu Lanfeng Bio-chemical Co Ltd market cap history from 2015 to 2026. Data shows change from $1.07 Billion to $234.13 Million (-10.44% CAGR). Check latest Jiangsu Lanfeng Bio-chemical Co Ltd stock price today for real-time trading data and today's change.
Jiangsu Lanfeng Bio-chemical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Lanfeng Bio-chemical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Jiangsu Lanfeng Bio-chemical Co Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.16x
Jiangsu Lanfeng Bio-chemical Co Ltd's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $890.13 Million | $1.46 Billion | $107.28 Million | 0.61x | 8.30x |
| 2017 | $551.26 Million | $1.85 Billion | $35.45 Million | 0.30x | 15.55x |
| 2018 | $357.25 Million | $1.48 Billion | -$874.95 Million | 0.24x | N/A |
| 2019 | $390.77 Million | $1.50 Billion | -$516.56 Million | 0.26x | N/A |
| 2020 | $217.65 Million | $1.34 Billion | $14.82 Million | 0.16x | 14.68x |
| 2021 | $274.26 Million | $1.44 Billion | -$491.19 Million | 0.19x | N/A |
| 2022 | $284.15 Million | $1.45 Billion | -$320.69 Million | 0.20x | N/A |
| 2023 | $380.33 Million | $1.74 Billion | -$332.26 Million | 0.22x | N/A |
| 2024 | $246.23 Million | $1.79 Billion | -$252.50 Million | 0.14x | N/A |
| 2025 | $369.34 Million | $2.34 Billion | -$190.53 Million | 0.16x | N/A |
Competitor Companies of 002513 by Market Capitalization
Companies near Jiangsu Lanfeng Bio-chemical Co Ltd in the global market cap rankings as of November 5, 2026. Also see how large is Jiangsu Lanfeng Bio-chemical Co Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Jiangsu Lanfeng Bio-chemical Co Ltd by market ranking:
- Nutrien Ltd (TO:NTR): Ranked #775 globally with a market cap of $34.64 Billion USD ( CA$47.89 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1396 globally with a market cap of $17.70 Billion USD ( CN¥120.97 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1468 globally with a market cap of $16.81 Billion USD.
- Yara International ASA (OL:YAR): Ranked #2100 globally with a market cap of $10.48 Billion USD ( Nkr99.63 Billion NOK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #775 | Nutrien Ltd | TO:NTR | $34.64 Billion | CA$100.36 |
| #1396 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $17.70 Billion | CN¥22.86 |
| #1468 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $111.68 |
| #2100 | Yara International ASA | OL:YAR | $10.48 Billion | Nkr391.20 |
Market Capitalization of Jiangsu Lanfeng Bio-chemical Co Ltd (2015–2026)
Market capitalization of Jiangsu Lanfeng Bio-chemical Co Ltd from 2015 to today. Between 2015 and today, Jiangsu Lanfeng Bio-chemical Co Ltd's market cap moved from $1.07 Billion to $ 234.13 Million, with a yearly change of -10.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥234.13 Million | -36.61% |
| 2025 | CN¥369.34 Million | +50.00% |
| 2024 | CN¥246.23 Million | -35.26% |
| 2023 | CN¥380.33 Million | +33.85% |
| 2022 | CN¥284.15 Million | +3.61% |
| 2021 | CN¥274.26 Million | +26.01% |
| 2020 | CN¥217.65 Million | -44.30% |
| 2019 | CN¥390.77 Million | +9.38% |
| 2018 | CN¥357.25 Million | -35.19% |
| 2017 | CN¥551.26 Million | -38.07% |
| 2016 | CN¥890.13 Million | -16.68% |
| 2015 | CN¥1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Jiangsu Lanfeng Bio-chemical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $234.13 Million USD |
| MoneyControl | $234.13 Million USD |
| MarketWatch | $234.13 Million USD |
| marketcap.company | $234.13 Million USD |
| Reuters | $234.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co.,Ltd engages in the production and processing of fungicide, insecticide, herbicide technicals and formulations, and chemical products in China and internationally. It offers carbendazim, thiophanate, fluticasone, benzoyl, cymoxanil, iprodione, imidacloprid, acetamiprid, pyrethroid, pyridaben, butylene, acetaminophen, lego, cycloazine, thiophanate-methyl, butylcarbo… Read more